The inhalable version of CanSino’s Recombinant Covid-19 Vaccine (Adenovirus Type 5 Vector) has received clinical trial approval in Malaysia, says Solution Group Bhd (SGB).
IT was a watershed moment when an elderly 91-year-old woman from the UK received the first Covid-19 vaccine injection.
Her inoculation symbolises the need to protect the vulnerable given the susceptibility of the elderly to the disease. It also shows the willingness to receive the jab that will allow everyone to get on with their lives in resuming the old normal in an increasingly new normal world.
Margaret Keenan’s vaccination was made possible after the UK government approved the Pfizer-BioNTech vaccine that broke all records in terms of approvals from the health authorities.
The race to finding a vaccine was top priority for the world given the vast damage the coronavirus has caused to lives and livelihoods, as seen from the wreckage it has caused to the global economy.